Amgen : AMGN

All Amgen Articles

701 Articles

Chris Lange | Dec 9, 2021 at 11:50 AM EST

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.

Lee Jackson | Dec 9, 2021 at 7:35 AM EST

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of…

Lee Jackson | Dec 6, 2021 at 8:53 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton…

Chris Lange | Nov 19, 2021 at 11:45 AM EST

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Friday afternoon's analyst upgrades and downgrades included Alibaba, AIG, Amgen, Applied Materials, Bath & Body Works, Delta Air Lines, Kohl’s,…

Lee Jackson | Nov 18, 2021 at 7:35 AM EST

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets,…

Lee Jackson | Nov 5, 2021 at 7:35 AM EDT

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

These five outstanding blue chip stocks have been hit hard this year and are offering growth and income investors incredible…

Lee Jackson | Oct 15, 2021 at 7:35 AM EDT

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

While not suited for conservative income investors, these two top biotech stocks could have huge total return potential and offer…

Lee Jackson | Sep 23, 2021 at 8:50 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.

Chris Lange | Sep 7, 2021 at 8:51 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology…

Chris Lange | Aug 24, 2021 at 9:35 AM EDT

6 Stocks Marjorie Taylor Greene Is Buying

24/7 Wall St. takes a look at Georgia Representative Marjorie Taylor Greene and what stock trades are going on around…

Lee Jackson | Mar 17, 2021 at 7:59 AM EDT

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

With the first quarter soon coming to an end, now is the time to move from momentum to strong growth…

Chris Lange | Jan 31, 2021 at 10:00 AM EST

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Paul Ausick | Jan 1, 2021 at 7:12 AM EST

2021’s Dogs of the Dow

The 2021 Dogs of the Dow are now known, and investors who may want to follow this investing strategy have…

Lee Jackson | Dec 29, 2020 at 9:07 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Amphenol, Continental Resources, EOG, FedEx, IMAX, Splunk and More

Tuesday's top analyst upgrades and downgrades included Amgen, Amphenol, Continental Resources, EOG Resources, FedEx, IMAX and Splunk.

Paul Ausick | Dec 22, 2020 at 8:32 AM EST

Meet the Preliminary Dogs of the Dow for 2021

One popular investment strategy, known as the Dogs of the Dow, has performed better than last year. What's ahead for…

1 … 6 7 8 9 10 … 47

Amgen : AMGN

All Amgen Articles

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

6 Stocks Marjorie Taylor Greene Is Buying

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

2021’s Dogs of the Dow

Top Analyst Upgrades and Downgrades: Amgen, Amphenol, Continental Resources, EOG, FedEx, IMAX, Splunk and More

Meet the Preliminary Dogs of the Dow for 2021

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Amgen : AMGN

All Amgen Articles

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

6 Stocks Marjorie Taylor Greene Is Buying

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

2021’s Dogs of the Dow

Top Analyst Upgrades and Downgrades: Amgen, Amphenol, Continental Resources, EOG, FedEx, IMAX, Splunk and More

Meet the Preliminary Dogs of the Dow for 2021

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings